General - Press Releases

Date	Title	Company
05-Dec-2023	Gossamer Bio Appoints Bob Smith as Chief Commercial Officer	Businesswire
05-Dec-2023	First Light Diagnostics Receives FDA Clearance for its Rapid B. anthracis Toxin Test on the MultiPath Analyzer	Newswire
05-Dec-2023	Alentis Therapeutics Doses First ANCA-Associated Vasculitis Rapidly Progressive Glomerulonephritis Patient in Phase 2 Clinical Trial of Lixudebart (ALE.F02)	Businesswire
05-Dec-2023	Star Therapeutics Appoints Matthew Fust as Independent Director and Board Audit Chair	Businesswire
05-Dec-2023	Seattle Children's launches BrainChild Bio to accelerate CAR T-cell therapies for children with brain tumors	Businesswire
05-Dec-2023	ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management	Businesswire
05-Dec-2023	U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy for the First-Line Treatment of Adult Patients with Unresectable or Metastatic...	Businesswire
05-Dec-2023	RIBOMIC Phase I and II Data Published in the Eye: Full TOFU/RAMEN/TEMPURA Trial Results Demonstrate Clinical Proof of Concept of Umedaptanib Pegol in Exudative Age-Related Macular Degeneration (nAMD)	Businesswire
05-Dec-2023	Lobe Sciences Provides Update on L-130 Oral Psilocin Compound	Businesswire
05-Dec-2023	KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Businesswire
05-Dec-2023	3Win Corp. Executes Definitive Agreement to Acquire Serenus Global, Inc.	Newswire
05-Dec-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
05-Dec-2023	AQEMIA Announces a Major Multi-year Collaboration of $140 Million With Sanofi	Businesswire
05-Dec-2023	Genentech Announces Positive Phase III Results for Inavolisib Combination in People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation	Businesswire
05-Dec-2023	LIVMARLI (maralixibat) di Mirum Pharmaceutical è stato ammesso al rimborso ed è ora disponibile in Italia per il trattamento del prurito colestatico in pazienti affetti da sindrome di Alagille	Businesswire
04-Dec-2023	Food And Drug Administration Grants Two New Label Changes To Tirosint®-Sol (Levothyroxine Sodium) Oral Solution	Businesswire
04-Dec-2023	Digital Health Strategies Closes Series A Funding Round to Expand Its Share of Health™ Patient Loyalty Platform	Businesswire
04-Dec-2023	Orano Med Announces Appointment of Dr. Volker Wagner as Chief Medical Officer	Businesswire
04-Dec-2023	CARMAT Announces the Opening of Its New Production Facility in Bois-d'Arcy, France	Businesswire
04-Dec-2023	Medefil Announces Availability of FDA-Approved Emergency Syringes, Atropine Sulfate Injection, USP, and 10% Calcium Chloride Injection, USP	Businesswire